LuTectomy: phase 1/2 study evaluating dosimetry, safety and potential benefit of pre-surgery [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in patients with high-risk localised prostate cancer

M. Hofman, R. Eapen, J. P. Buteau, P. Jackson, C. Mitchell, S. Oon, O. Alghazo, L. McIntosh, N. Dhiantravan, J. O'Brien, A. Mcvey, S. Sandhu, A. A. Azad,S. G. Williams, G. Sharma, B. Emmerson, M. B. Haskali, M. Bressel, D. Moon, N. Lawrentschuk, P. Neeson, D. G. Murphy

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2023）

引用 0|浏览1

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

LuTectomy: phase 1/2 study evaluating dosimetry, safety and potential benefit of pre-surgery [177Lu]Lu-PSMA-617 radioligand therapy in patients with high-risk localised prostate cancer

LuTectomy: phase 1/2 study evaluating dosimetry, safety and potential benefit of pre-surgery [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in patients with high-risk localised prostate cancer